SelectQuote

SelectQuote, Inc. operates as a technology-enabled, direct-to-consumer distribution platform that provides consumers with a transparent and convenient venue to shop for complex senior health, life, and auto and home insurance policies from a curated panel of insurance carriers. The company operates through three business lines: SelectQuote Senior, SelectQuote Life, and SelectQuote Auto and Home. The SelectQuote Senior provides unbiased comparison shopping for Medicare Advantage and Medicare Supplement insurance plans as well as prescription drug plan, dental, vision and hearing and critical illness products. The SelectQuote Life offers unbiased comparison shopping for life insurance and ancillary products including term life, guaranteed issue, final expense, accidental death and juvenile insurance. The SelectQuote Auto and Home manages a comparison-shopping platform for auto, home and specialty insurance lines. The company was founded on August 18, 1999 and is headquartered in Overland Park, KS.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

SelectQuote reports strong Q3 earnings and positions for Medicare Advantage growth

SelectQuote's Q3 earnings call highlighted strong financial performance, increased guidance for fiscal 2023, and effective cost management strategies. The company's focus on Healthcare Services and partnership with Wellcare-Centene position it for growth. While not providing guidance for fiscal year 2024, the company is confident in its ability to navigate regulatory changes and capitalize on opportunities in the Medicare Advantage industry.

SelectQuote reports stellar Q2 results, focuses on profitability and growth

SelectQuote's Q2 2023 earnings call highlighted robust financial performance, strategic focus on profitability, and operational efficiency. The company's emphasis on sustainable growth, improved cash flow projections, and reduced seasonality impact present promising opportunities for future success.

SelectQuote surpasses Q3 forecasts, eyes growth in Medicare Advantage

SelectQuote's Q3 performance exceeded forecasts, showcasing financial progress and stability in the Senior business. The company's value to Medicare Advantage carriers and strong growth in the SelectRx segment are key strengths. Challenges include category split clarity and maintaining consumer experience amidst compliance efforts. Opportunities lie in increased guidance ranges, agent force management, and capitalizing on healthcare opportunities for seniors.

SelectQuote reports robust fiscal 2023 performance and strategic growth

SelectQuote's fiscal 2023 showcased strong performance, strategic positioning, and growth potential in key segments like Senior and Healthcare Services.
While facing challenges in Senior growth and cash flow, the company's focus on profitability, agent retention, and lead targeting strategies bode well for future success.
By leveraging existing strengths and addressing challenges, SelectQuote aims to drive durable EBITDA margins, maintain positive EBITDA contribution in Healthcare Services, and approach operating cash flow positivity in fiscal '24.

SelectQuote reports stable Q1 earnings, sees growth in Healthcare Services

SelectQuote's Q1 2024 earnings call highlighted stable profitability, strong business performance in the Senior and Healthcare Services segments, and a focus on enhancing technology and agent-led strategies. Despite challenges in EBITDA, the company's unique value proposition presents opportunities for future growth and success.

SelectQuote exceeds Q2 expectations, boosts outlook on strong performance

SelectQuote's strong Q2 performance underscores its resilience and growth potential in core business segments.
Despite challenges in balance sheet restructuring and cash flow, the company's upward revision of financial outlook signals confidence in future prospects.
By leveraging strengths in senior and health care services, SelectQuote aims to drive shareholder value and sustain growth momentum.

SelectQuote exceeds Q3 expectations, raises revenue outlook for fiscal '24

SelectQuote delivered strong Q3 results, exceeding revenue expectations and demonstrating growth in key segments. The company's focus on improving funding costs, leverage, and profitability positions it well for future growth. Challenges lie in managing balance sheet, margin improvements, and balancing growth with profitability in healthcare services.

SelectQuote reports successful FY 2024, eyes growth amid challenges

SelectQuote's fiscal year 2024 showcased strong performance in key segments but anticipates challenges in growth for 2025. The company's focus on improving capital structure and pursuing growth opportunities positions it well for the future.

SelectQuote reports strong Q1 performance, eyes growth in healthcare

SelectQuote's Q1 2025 earnings call highlighted positive performance across key segments, with a focus on growth, profitability, and strategic investments. The company's ability to raise capital, provide updated guidance, and address analyst inquiries underscores its commitment to driving shareholder value and industry leadership. Challenges in agent productivity and strategic decision-making present areas for continued focus and improvement.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

SelectQuote, Inc. operates as a holding company, which engages in the provision of insurance policies and healthcare services. It operates through the following segments: Senior, Healthcare Services, Life, and Auto & Home. The Senior segment primarily sells senior Medicare-related health insurance products. The Healthcare Services segment provides products and services focusing on improving patient health outcomes. It includes SelectRx, Population Health, and SelectPatient Management. The Life segment engages in the sale of term life and final expense products. The Auto & Home segment sells individual automobile and homeowners insurance. The company was founded on August 18, 1999 and is headquartered in Overland Park, KS.

SelectQuote (SLQT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate SelectQuote (SLQT) to Report a Decline in Earnings: What to Look Out for

OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT), a pioneer in providing consumers with unbiased price comparisons from some of the most trusted insurance carriers, announced today it will release its fiscal third quarter 2022 financial results before the market opens on Thursday, May 5, 2022. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Raff Sadun, will host a conference call on the day of the release (May 5, 2022) at 8:30 am ET to discuss the results.

SelectQuote to Release Fiscal Third Quarter 2022 Earnings on May 5

NEW YORK--(BUSINESS WIRE)-- #Class--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against SelectQuote, Inc. (NYSE: SLQT) on behalf of long-term stockholders following a class action complaint that was filed against SelectQuote on August 16, 2021 with a class period from May 20, 2020 to August 25, 2021 or in relation to the company's May 20, 2020 IPO. Our investigation concerns whether the board of directors of SelectQuote have bre

SELECTQUOTE ALERT: Bragar Eagel & Squire, P.C. is Investigating SelectQuote, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

New York, New York--(Newsfile Corp. - March 14, 2022) - Pomerantz LLP is investigating claims on behalf of investors of SelectQuote, Inc. ("SelectQuote" or the "Company") (NYSE: SLQT). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether SelectQuote and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SelectQuote, Inc. - SLQT

NEW YORK--(BUSINESS WIRE)-- #Class--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT) on behalf of SelectQuote stockholders. Our investigation concerns whether SelectQuote has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On February 7, 2022, SelectQuote reported its financial res

SELECTQUOTE ALERT: Bragar Eagel & Squire, P.C. is Investigating SelectQuote, Inc. on Behalf of SelectQuote Stockholders and Encourages Investors to Contact the Firm

OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) announced the formation of a Healthcare Advisory Board to help the company strengthen the mission and clinical strategy of Population Health. This group of world-class experts will advise Population Health on ways to empower, engage and educate consumers on healthcare solutions and benefits, equipping them to lead healthier lives through improved health outcomes while reducing costs for patients and the healthcare system. This

SelectQuote Introduces Healthcare Advisory Board

NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT). Investors who purchased SelectQuote shares are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/slqt. The investigation concerns whether SelectQuote and certain of its officers and/or directors have violated federal s

Bronstein, Gewirtz & Grossman, LLC Notifies SelectQuote, Inc. (SLQT) Investors of Investigation

This online insurance broker is having an awful day.

Here's Why This Insurance Stock Is Down by Nearly 50% Today

The stock price of SelectQuote Inc (NYSE: SLQT) fell by over 50% pre-market today. This is why it happened.

SelectQuote (SLQT) Stock: Why The Price Substantially Fell Today

Philadelphia, Pennsylvania--(Newsfile Corp. - February 8, 2022) - Kaskela Law LLC announces that it is investigating SelectQuote, Inc. ("SelectQuote" or the "Company") (NYSE: SLQT) on behalf of the Company's stockholders. Recently a securities fraud complaint was filed against SelectQuote on behalf of certain investors who purchased shares of the Company's common stock between May 20, 2020 and August 25, 2021. According to the complaint, during that time period SelectQuote allegedly "repeatedly reported inflated...

Kaskela Law LLC Announces Stockholder Investigation of SelectQuote, Inc. (SLQT) and Encourages Long-Term SLQT Shareholders to Contact the Firm

SelectQuote, Inc. (SLQT) CEO Timothy Danker on Q2 2022 Results - Earnings Call Transcript

OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue for the second quarter of fiscal year 2022 of $195.0 million compared to consolidated revenue for the second quarter of fiscal year 2021 of $357.6 million. Consolidated net loss for the second quarter of fiscal year 2022 was $137.0 million compared to consolidated net income for the second quarter of fiscal year 2021 of $89.9 million. Finally, consolidated Adjusted EBITDA* for the second quarter o

SelectQuote, Inc. Reports Second Quarter of Fiscal Year 2022 Results

SelectQuote (SLQT) Earnings Expected to Grow: Should You Buy?

OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT), a pioneer in providing consumers with unbiased price comparisons from some of the most trusted insurance carriers, announced today that it will release its fiscal second quarter 2022 financial results after the market closes on Monday, February 7, 2022. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Raff Sadun, will host a conference call on the day of the release (February 7, 2022) at 5:00 pm ET to discuss

SelectQuote to Release Fiscal Second Quarter 2022 Earnings on February 7

SelectQuote went public in May 2020 in an IPO that sold $570 million worth of company shares and selling shareholder stock.

SelectQuote Appears Well Positioned For All-Important Q4

Shares of SelectQuote have sunk more than 50% year to date. While the company has issued possibly worrying commentary about customer churn, the sharp fall in the stock price has more than compensated for that risk.

SelectQuote: Ignore Sentiment, And Stick To Fundamentals

SelectQuote, Inc. (SLQT) CEO Raff Sadun on Q3 2021 Results - Earnings Call Transcript

SelectQuote (SLQT) delivered earnings and revenue surprises of 9.68% and 15.74%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

SelectQuote (SLQT) Reports Q1 Loss, Tops Revenue Estimates

OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue for the first quarter of fiscal year 2022 of $159.9 million, which was a 29% increase over consolidated revenue for the first quarter of fiscal year 2021 of $124.2 million. Consolidated net loss for the first quarter of fiscal year 2022 was $45.4 million, which represents a decrease in consolidated net income of $46.2 million over consolidated net income for the first quarter of fiscal year 2021 o

SelectQuote, Inc. Reports First Quarter of Fiscal Year 2022 Results

HOUSTON--(BUSINESS WIRE)--BrainCheck, the cognitive healthcare platform for physicians, today announced $10 million in Series B funding. The round is led by Next Coast Ventures and S3 Ventures, with additional investors including Nueterra Capital, Tensility Ventures, and True Wealth Ventures. In addition, UPMC Enterprises and SelectQuote (NYSE: SLQT) have joined as strategic investors. The round takes the total capital raised by BrainCheck to date to $20 million. “We are at the forefront of imp

BrainCheck Raises $10 Million in Series B Funding to Transform Cognitive Health Assessment and Care for Alzheimer's and Related Dementias

OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) announced a new partnership today with Ready Responders, which utilizes an innovative care delivery model to provide non-emergency healthcare services to patients in their homes. Population Health will provide education and awareness for members around Ready Responders' program, giving the knowledge and tools they need to access high-quality healthcare in a timely and convenient manner. In line with these efforts, Population H

Population Health Partners With Ready Responders

SAN DIEGO, Oct. 20, 2021 /PRNewswire/ -- Johnson Fistel, LLP is investigating potential claims on behalf of SelectQuote Inc. ("SelectQuote" or the "Company") (NYSE: SLQT) against certain of its officers and directors.  Recently a class action lawsuit was filed in federal court against the Company on behalf of purchasers of the securities of SelectQuote from May 20, 2020 and August 25, 2021 (the "Class Period").

SelectQuote Long-Term Investor Alert: Did You Acquire SelectQuote Inc. Before May 20, 2020? Should Management be Held Accountable for Investors Losses?

OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT), a pioneer in providing consumers with unbiased price comparisons from some of the most trusted insurance carriers, announced today that it will release its fiscal first quarter 2022 financial results after the market closes on Thursday, November 4, 2021. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Raff Sadun, will host a conference call on the day of the release (November 4, 2021) at 5:00 pm ET to discus

SelectQuote to Release Fiscal First Quarter 2022 Earnings on November 4

New York, New York--(Newsfile Corp. - October 15, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of SelectQuote, Inc. (NYSE: SLQT): (i) pursuant and/or traceable to the Company's initial public offering conducted on or around May 20, 2020 (the "IPO" or "Offering"); and/or (ii) between May 20, 2020 and August 25, 2021, inclusive (the "Class Period"), of the important October 15, 2021 lead plaintiff deadline.SO WHAT:...

SLQT Final Deadline Today: Rosen, National Trial Counsel, Encourages SelectQuote, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 15 Deadline in Securities Class Action - SLQT

Los Angeles, California--(Newsfile Corp. - October 14, 2021) -  The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SelectQuote, Inc. ("SelectQuote" or "the Company") (NYSE: SLQT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between February 8, 2021 and May 11, 2021, inclusive (the...

DEADLINE TOMORROW ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against SelectQuote, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

News for SelectQuote Stock (SLQT)